CARE reaffirms ratings assigned to Hester Biosciences’ bank facilities

22 Mar 2016 Evaluate

Credit rating agency, CARE has reaffirmed ‘BBB+’ rating to Hester Biosciences’ long-term bank facilities worth Rs 34.19 crore. The rating agency has also reaffirmed ‘BBB+/ A3+’ rating to company’s long-term/ short term bank facilities worth Rs 25 crore. The ratings assigned to the bank facilities of Hester Biosciences (HBL) continue to derive strength from its experienced promoters, established position in the poultry vaccine industry, strong marketing and distribution network and its wide product portfolio.

The ratings also continue to take into account consistent growth in its total operating income along with healthy profitability and comfortable capital structure and debt coverage indicators.

Hester Biosciences Share Price

1649.00 17.95 (1.10%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×